Lo Andrew sold BBIO

November 17, 2025 · Form 4 insider transaction

Lo Andrew sold 3,798 shares of BridgeBio Pharma, Inc. at $67.06 per share, a transaction worth $254.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,798
Price
$67.06
Total value
$254.7K
InsiderLo Andrew
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after14,089
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR